Document is current
Any future updates will be listed below
-
Authors
Braun, Madelene
Bjurnemark, Caroline
Seo, Woosung
Freyhult, Eva
Nyholm, Dag
Niemelä, Valter
Blennow, Kaj
Zetterberg, Henrik
Fällmar, David
Kultima, Kim
Virhammar, Johan https://orcid.org/0000-0001-9901-2949
-
Funding
Funding for this research was provided by:
Svenska Sällskapet för Medicinsk Forskning
- License Information
-
More Information
Article History
Received: 23 September 2021
Accepted: 15 January 2022
First Online: 14 February 2022
Change Date: 16 May 2022
Change Type: Update
Change Details: In the online version of this article, there was a typo in the funding note. The article has been updated.
Declarations
:
: The study was approved by the Swedish National Ethical Review Authority (Dnr 2015/174/3 and 2019-06566).
: HZ has served at scientific advisory boards for Alector, Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies and CogRx, has given lectures at symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, which is a part of the GU Ventures Incubator Program, all unrelated to the work presented in this paper.KB has served as a consultant, on advisory boards, or in data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, which is a part of the GU Ventures Incubator Program, all unrelated to the work presented in this paper.
